1-4 of 4
Diane Heiser, PhD
Close
Sort by
Journal Articles

A Feasibility Study of Biologically Focused Therapy for Myelodysplastic Syndrome Patients Refractory to Hypomethylating Agents

Michael A Spinner, Alexey Aleshin, MD MBA, Marianne A Santaguida, PhD, Steven A Schaffert, PhD, Taher Abbasi, MS, MBA, Jeffrey N Sanders, A Scott Patterson, MA, Diane Heiser, PhD, James L Zehnder, Peter L Greenberg, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4239.
https://doi.org/10.1182/blood-2019-129473
Published: 2019
Journal Articles

PTC299 Is a Novel DHODH Inhibitor That Modulates VEGFA mRNA Translation and Inhibits Proliferation of a Broad Range of Leukemia Cells

Liangxian Cao, MD, Arthur Branstrom, PhD, John Baird, PhD, Christopher Trotta, PhD, Joseph Colacino, PhD, Marianne T. Santaguida, BSc, PhD, Diane Heiser, PhD BA, Mark Ma, PhD, Kensuke Kojima, MD PhD, Stuart Peltz, PhD, Edward O'Mara, MD, Robert Spiegel, MD, Marla Weetall, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1371.
https://doi.org/10.1182/blood.V130.Suppl_1.1371.1371
Published: 2017
Journal Articles

Ex Vivo High-Throughput Flow Cytometry Screening Identifies Subsets of Responders to Differentiation Agents in Individual AML Patient Samples

Sacha L. Prashad, PhD, Leylah Drusbosky, PhD, Hassan Sibai, MD, Mark D. Minden, MD PhD, Stephen J. Western, Chris Biondi, MS, Reecha Shah, MS, Debra Liu, MS, Transon Nguyen, MS, Connor Warnock, BS, Pete Quinzio, BA, Matthew De Silva, BS, Elie Traer, MD, Christopher R. Cogle, MD, Aaron D. Schimmer, MD PhD, Diane Heiser, PhD
Journal: Blood
Blood (2016) 128 (22): 5206.
https://doi.org/10.1182/blood.V128.22.5206.5206
Published: 2016
Journal Articles

Dnmt3a Deletion Cooperates with the Flt3-ITD Mutation to Drive Leukemogenesis in a Murine Model

Jennifer L Poitras, BS, Diane Heiser, PhD, Li Li, PhD, Bao Nguyen, M.S., Amy S. Duffield, MD PhD, Christopher Gamper, MD PhD, Donald Small, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3568.
https://doi.org/10.1182/blood.V124.21.3568.3568
Published: 2014